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Abstract 
Background: Upon awaking, many Parkinson’s patients experience an improved mobility, a phenomenon known as 
‘sleep benefit’. Despite the potential clinical relevance, no objective correlates of sleep benefit exist. The discrepancy 
between the patients’ subjective experience of improvement in absence of objective changes is striking, and raises 
questions about the nature of sleep benefit. We aimed to clarify what patients reporting subjective sleep benefit, 
actually experience when waking up. Furthermore, we searched for factors associated with subjective sleep benefit.
Methods: Using a standardized topic list, we interviewed 14 Parkinson patients with unambiguous subjective sleep 
benefit, selected from a larger questionnaire-based cohort. A grounded theory approach was used to analyse the 
data.
Results: A subset of the participants described a temporary decrease in their Parkinson motor symptoms after sleep. 
Others did experience beneficial effects which were, however, non-specific for Parkinson’s disease (e.g. feeling ‘rested’). 
The last group misinterpreted the selection questionnaire and did not meet the definition of sleep benefit for various 
reasons. There were no general sleep-related factors that influenced the presence of sleep benefit. Factors mentioned 
to influence functioning at awakening were mostly stress related.
Conclusions: The group of participants convincingly reporting sleep benefit in the selection questionnaire appeared 
to be very heterogeneous, with only a portion of them describing sleep benefit on motor symptoms. The group of 
participants actually experiencing motor sleep benefit may be much smaller than reported in the literature so far. 
Future studies should employ careful inclusion criteria, which could be based on our reported data.
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Background
Parkinson’s disease is a neurodegenerative disorder with 
motor symptoms primarily characterised by stiffness 
and slowness of movement. Many patients also experi-
ence non-motor symptoms such as cognitive problems, 
depression and sleep disorders. Although sleep disorders 
are highly prevalent in Parkinson’s disease [1], there are 
also patients that report beneficial effects of sleep. Upon 
awaking in the morning, many patients experience an 
improved mobility as if they are in a medication-induced 
“on” state, contrary to what would be expected after a 
night without medication. This phenomenon is known as 
sleep benefit [2]. Some Parkinson patients even state to 
delay or forget their morning dose of medication because 
of this sleep benefit [3, 4].
In questionnaire studies on sleep benefit, 30–55  % of 
the patients reports to be familiar with the phenomenon 
[3–5]. One study described an improvement in clinical 
motor examination (UPDRS-III) after sleep in patients 
that experienced sleep benefit [6]. However, results from 
a recent study by our group on objective motor improve-
ment in sleep benefit showed a different picture. We used 
two quantitative motor tasks to assess sleep benefit in 
Parkinson patients. We found no objective sleep-related 
improvement in Parkinson signs in patients who none-
theless declared to experience subjective sleep benefit [7].
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The discrepancy between the patients’ experience 
of sleep benefit in absence of objective improvement 
is striking, and raises questions about the nature of the 
sleep benefit phenomenon [7]. The origin and character-
istics of subjective sleep benefit are still unclear. Because 
of the use of closed-end questions in previous sleep ben-
efit research, it is not known what kind of improvement 
patients refer to when they report sleep benefit. It seems 
reasonable to make a distinction between (1) a subjective 
general feeling of improvement after sleep and a (2) spe-
cific improvement in actual motor functioning, as prob-
ably both are perceived as sleep benefit by Parkinson’s 
patients [4]. More insight in the subjective experiences of 
patients who report sleep benefit, could be key in under-
standing this phenomenon.
Qualitative research methods provide a powerful tool 
for a more profound understanding of subjective experi-
ences [8–10]. We performed a qualitative interview study 
to obtain more insight in what patients who report sleep 
benefit, experience when they wake up. Furthermore, we 




A flow chart of the inclusion process can be found in 
Fig. 1. Parkinson patients were recruited from a cohort of 
237 patients that participated in a previous questionnaire 
study on sleep benefit [4]. In this questionnaire the fol-
lowing definition/explanation of sleep benefit was used: 
sleep benefit is the experience of a temporary decrease in 
Parkinson’s symptoms upon awakening after a period of 
sleep (night or daytime), before drug intake; the patient 
is feeling as good as “on” (or better) [11]. For this study 
we only selected Parkinson patients that reported sleep 
benefit in the questionnaire (n = 74). We used purposive 
sampling. With this method, subjects are not randomly 
selected, but chosen based on individual characteris-
tics. The purpose of this method is to make the sample 
as diverge as possible. Furthermore, the open-end ques-
tion in which patients gave a description of their morn-
ing experience was leading in the selection: we invited 
patients who, based on their own description, were most 
probable—in our clinical view- to experience some sort 
of sleep benefit. Subjects giving a description indicative 
of misunderstanding the definition of sleep benefit given 
in the questionnaire were not invited. Inclusion of sub-
jects and initial coding of the interviews were performed 
in parallel. New patients were included until data satu-
ration was reached. This means that the last interviews 
provided no new information and no more new codes 
emerged from the coding process.
In total, information letters about the study were sent 
to 16 Parkinson patients. These patients were contacted 
by telephone to provide general study information and—
when interested—to book an appointment for the inter-
view. After telephone consultation, all subjects agreed to 
participate.
We included patients with idiopathic Parkinson dis-
ease, defined according to the UK Brain Bank criteria, 
Hoehn and Yahr stage I–IV. All patients were fluent in 
Dutch. Exclusion criteria included current major psychi-
atric or cognitive disorders. The study was approved by 
the institutional medical ethical committee (file no. 2014-
1355). All participants gave their written informed con-
sent before participating.
Interviews
For the semi-structured interview with open questions, 
we used an interview guide. Initially the interview guide 
only contained a few very wide scoped questions. Partici-
pants were invited to tell everything they considered rel-
evant, without steering them into a certain direction.
Participants were asked how they experienced their 
symptoms at waking up. Both night sleep and daytime 
naps were evaluated. Questions on day-to-day variation 
in functioning gave more insight in factors that could 
influence sleep benefit. Later in the series we added more 
focussed questions on various specific Parkinson symp-
toms and aspects of sleep quality. Probing questions were 
used to follow up whenever necessary. The interviews 
took place at the participant’s home. Interviews lasted 
about 30–45  min and were recorded and later tran-
scribed verbatim by the interviewer.
The interviewer (ICC) was trained and experienced 
in taking interviews. She was new to the field of sleep 
benefit, as such she was open to whatever the partici-
pants presented and had no preconceptions about the 
phenomenon.
Analyses
A grounded theory approach was used to analyse the 
data [8]. The interviews were read and re-read to become 
familiar with the data. Initial open coding was performed 
by two researchers (MvG and ICC) independently to 
increase reliability. All codes were compared and con-
trasted until consensus was met. This was followed by 
an axial coding process, in which codes were sorted and 
classified into recurring themes. All researchers from the 
multidisciplinary team were involved in the development 
of the final thematic structure. Generally, differences in 
interpretation between researchers were small and con-
sensus was rapidly achieved. All ideas and questions that 
were raised during the analytical process, were registered 
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in memo’s. A computer software package, Atlas.ti (ver-
sion 7), was used to manage the data.
Results
A total of 14 Parkinson patients (5 men, 36  %) were 
included in the analyses. One interview was cancelled 
because the participant was admitted to the hospital. 
Another interview was excluded because the participant 
had surgery for deep brain stimulation (DBS) and did not 
experience any Parkinson symptoms ever since (Fig.  1). 
She could not remember much about her symptoms at 
waking up before the DBS, i.e. the time she completed 
the inclusion questionnaire.
Age of the participants ranged from 55 to 75  years 
(mean 61 years). Disease duration (from onset of first 
symptoms) ranged from 5 to 30 years (mean 13 years). All 
Fig. 1 Flow chart patient inclusion
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patients used dopaminergic medication; 13 patients used 
l-dopa and 8 patients (also) used dopamine agonists.
After coding of the data two central themes emerged. 
(1) Experiences at waking up, which could be divided in 
the sub-themes physical functioning and mental func-
tioning and (2) Factors that influenced functioning at 
awakening, which included sleep related factors and 
other factors.
Experiences at waking up
When participants told about their experiences at wak-
ing up, these could be divided into two sub-themes; 
physical functioning and mental functioning, in which 
participants described their physical/mental abili-
ties at waking up. Both sub-themes had ‘positive’ and 
‘negative’ categories, containing codes that indicated 
functioning that was notably good at awakening or -in 
contrast- functioning that was affected by the Parkin-
son’s disease. The physical theme contained codes for 
different kinds of actions and symptoms, such as get-
ting out of bed, walking and tremor. In the mental 
theme we identified codes for different aspects of men-
tal functioning, such as feeling relaxed, feeling rested 
and feeling energetic.
Based on the co-occurrence of different codes within 
this theme, we distinguished three interpretations of 
sleep benefit: (1) patients that described motor sleep ben-
efit (n = 6), (2) patients without sleep benefit (n = 5) and 
(3) patients that experienced unclassified sleep effects, i.e. 
some sort of improvement that was not clearly sleep ben-
efit (n = 3).
Motor sleep benefit
The six patients in this group clearly described a decrease 
in Parkinson-specific motor symptoms. At waking up 
they find it easier to perform all sorts of movements, 
such as getting out of bed, walking, getting dressed, writ-
ing and household tasks. Furthermore, some patients 
experienced less tremor and freezing of gait.
“I just get out of bed and walk. I don’t have to sit on 
the side of the bed first, I can get up without effort.” 
(P5, night)
“Yes, then my handwriting is fine, however that 
expires within half an hour, then it’s over.” (P6, night)
“the first half hour in the morning, I would describe 
it as feeling ‘on’” (P6, night)
“But the tremor, I don’t feel, I don’t have it when I 
wake up” (P14, night)
“Well, I go to the kitchen for example, and it is easy 
to clean the countertop, or eh, to make sandwiches, 
that kind of things. And I do not stick to the ground.” 
(P1, nap)
Although moving was easier, most of these patients did 
experience stiffness when getting out of bed.
“Getting dressed is easier, but walking is stiff. Tasks 
in the kitchen are trouble-free” (P1, night)
“I feel a little stiff, but that’s it. In the morning I’m at 
my best” (P4, night)
Patients with motor sleep benefit described a clear 
limited duration of the effects, ranging from 30  min to 
2  h. All patients experienced an improvement in motor 
functioning after night sleep. Some patients also reported 
motor benefit of an afternoon nap or when waking up 
during the night. Many patients also reported a mental 
benefit of sleep, mostly in terms of ‘feeling well rested’.
No sleep benefit
These 5 patients did not meet the definition of sleep ben-
efit for various reasons. For example, some patients expe-
rienced many symptoms at awakening. Therefore, they 
took their morning medication in bed and waited in bed 
until it started working. The described ease with getting 
out of bed was clearly a medication effect rather than a 
sleep effect. Other patients needed their medication at 
waking up, however, overall they felt better in the morn-
ing than in the afternoon. There was also a patient who 
described that a good night of sleep was very beneficial 
for functioning during the whole next day. So the effect 
was not specific for the first moments after waking up, 
but rather an all day ‘bonus’ that worked on top of the 
normal medication.
Unclassified sleep effects
There were three patients that did not fit in either the 
motor sleep benefit or the no sleep benefit group. These 
patients reported to feel good at waking up. However this 
improvement mostly seemed to be a mental rather than a 
physical change. Patients described feeling relaxed, ener-
getic, clear headed or peaceful. This state of mind was 
reflected in overall functioning, but Parkinson specific 
motor symptoms were present explicitly at awakening.
“That is not really a physical thing, but in my head, 
I feel really relaxed. Whatever happens, I just let it 
happen without fighting it. So there is more comfort in 
my body maybe. I don’t worry so much or think ‘what-
ever’. And then I am able to get up calmly.” (P2, night)
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“Yes, yes, my body is relaxed, it feels very pleasant, 
a positive feeling. It has something to do with mood. 
That’s the biggest difference, when you feel relaxed, 
your body, your mood is ten times better. That is the 
largest benefit.” (P2, night)
“It is like calmness comes into your body, relaxa-
tion in your head. And I am a busy bee, but then it 
is just, I can let everything go. Like recharging, I feel 
invigorated.” (P8, nap)
“See, before I take a nap, I’m exhausted, especially 
in my head. I close my eyes and fall asleep immedi-
ately. Well, if I’m tired, my whole body, everything is 
difficult. But when I wake up I feel as fit as a fiddle 
so to say (laughs), then it’s just fine.” (P9, nap)
In this group, the described beneficial effects of sleep 
could occur after night sleep, an afternoon nap or both. 
The benefit started at the moment of waking up, however, 
these patients did not indicate a clear duration of the 
phenomenon.
One patient took her medication in bed and slept until 
the medication started working. Sometimes she woke up 
feeling exceptionally good. Other mornings getting out of 
bed was very troublesome.
“Well, when I wake up feeling relaxed, taking a 
shower is easier. I can just move more easily. […] 
And when I don’t wake up feeling relaxed, when 
I start stiffening, that uncomfortable feeling, then 
washing myself is difficult.” (P9, night)
Factors that influenced functioning at awakening
Influence of sleep factors
There was large variation in self described sleep quality 
between patients. We could not identify any concurrent 
patterns in the different sleep benefit groups. Notably 
almost all patients described to experience REM sleep 
behaviour-like symptoms, such as vivid dreaming, (vio-
lent) movements and speech during sleep.
Some patients reported factors that could influence 
the magnitude of the beneficial effects of sleep. Total 
sleep duration, number of awakenings, presence of 
vivid dreams and bedtime were mentioned. However, 
there were also patients who denied the influence of 
these factors or were not aware of any contributing fac-
tors at all.
Some patients experienced the same amount of motor 
benefit after an afternoon nap as after a night of sleep. 
Others reported to benefit from a nap as well, but to a 
lesser extent. Some patients mentioned that this could be 
because naps have a shorter duration. Only a number of 
patients experiencing unclassified sleep effects had more 
benefit of a nap than of a night of sleep.
Other factors
Many patients, both with and without sleep benefit, 
described a negative influence of stress on their symp-
toms at waking up. If they had an appointment in the 
morning and had to hurry through their morning rituals 
they felt less comfortable and experienced more Parkin-
son’s symptoms.
On the other hand, there was also one patient that 
praised the silence of the night as the best influence on 
his symptoms:
“Yes, the difference is that there is nothing around 
me. It’s dark, there is nobody there, nobody active 
and I can just without any, anything around me, 
there is no disturbance. […] no influence from out-
side, that’s easier.” (P2, night)
Some patients described that not only sleep or a nap 
had positive effects, but also taking rest, without sleeping 
could reduce tremor or give more energy.
Discussion
In this grounded theory study, we interviewed patients 
with self-reported sleep benefit about their functioning 
at waking up and about the factors that could influence 
their abilities at awakening. We showed that some, but 
certainly not all, patients with self-reported sleep benefit 
experience a temporal decrease in their Parkinson motor 
symptoms. Several patients did not meet the definition of 
sleep benefit at all. Others experienced beneficial effects 
of sleep, however, not a specific decrease of motor symp-
toms. There were no general sleep related factors that 
influenced the presence of sleep benefit. Other factors 
that were mentioned to influence functioning at awaken-
ing were mostly stress related.
For this study we selected patients that, by all available 
means, were likely to experience sleep benefit, selected 
from a large cohort of patients that reported sleep benefit 
in a questionnaire. Surprisingly, a substantial part of the 
interviewed patients did not meet the definition of sleep 
benefit, that was presented in the questionnaire, for vari-
ous reasons. In all these cases, patients did not take into 
account a crucial part of the definition of sleep benefit. 
They mainly disregarded the statement that sleep ben-
efit is experienced before the intake of medication or that 
sleep benefit is a temporal effect, specific for the moment 
of waking up.
In previous studies on objective motor improvement 
in patients with sleep benefit, questionnaires were used 
for the selection of participants [6, 7]. Our data show that 
this inclusion method may result in a very heterogeneous 
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group of participants. Probably patients without sleep 
benefit or with unclassified sleep effects participated 
in those studies as well. This may –in part- explain why 
no motor effects of sleep benefit have been found. It 
would be interesting to study whether patients with 
self-described motor sleep benefit show objective motor 
improvement after sleep. Our data show that the careful 
inclusion of patients in such a study is very important. 
Based on these interviews we could not find differentiat-
ing factors for motor sleep benefit. In future studies an 
extensive interview will be the best way to distinguish 
patients with sleep benefit from those without.
Three participants did not describe classical motor 
sleep benefit. However, they did experience some ben-
eficial effects of sleep, mostly mental benefit. The mental 
improvement described by these patients was not a Par-
kinson specific effect of sleep, but rather a subjective gen-
eral feeling of improvement. It could be argued whether 
this should be regarded a form of sleep benefit. For these 
patients, it directly benefited their coping with the dis-
ease. Therefore, we think that also this phenomenon 
could be clinically interesting, but the underlying mech-
anisms are probably different from motor sleep benefit. 
So, it is important to make a clear distinction between 
both phenomena.
We could not find sleep related factors that clearly 
influenced the occurrence of sleep benefit. Some partici-
pants did experience a relation between sleep quality and 
the amount of sleep benefit, however, there were large 
individual differences. Based on the small number of 
patients with motor sleep benefit in this sample, we can-
not draw conclusions on this matter.
The other factors that participants described that influ-
enced their functioning at waking up were not specific 
for sleep benefit. Factors such as stress were also con-
sidered disabling during the rest of the day and are often 
reported by Parkinson’s patients [12]. On the other hand, 
some participants described feeling relaxed, peaceful or 
clearheaded after sleep, as if sleep had a stress reduc-
ing effect. In fybromialgia and rheumatoid arthritis, 
good sleep has a beneficial effect on coping with stress-
ful events [13]. So, maybe in these cases sleep does not 
have a direct effect on functioning, but the effect is medi-
ated by a reduction of stress or negative affect. Some par-
ticipants also described beneficial effects of taking rest, 
without sleeping. This could have a stress and fatigue 
reducing effect as well.
In studies on objective motor function in sleep benefit, 
patients had to perform motor tasks directly at waking up 
[6, 7]. This could have been consciously or unconsciously 
stressful for the participants. At least the experimental 
setting differed from their standard morning routine, 
which many patients considered important in this study. 
This could have contributed to the lack of motor effects 
found in the quantitative studies on sleep benefit.
Notably, many patients, also amongst those with motor 
sleep benefit, described feeling stiff at waking up. How-
ever, as some patients added, this could also be a general 
sign of aging instead of a specific Parkinson symptom. 
Some participants noted the same stiffness at waking up 
with their spouses, who were not diagnosed with Parkin-
son’s disease.
For some participants it was difficult to find the exact 
words to describe their functioning at awakening. To 
help these participants, the interviewer asked probing 
questions on morning routines and activities. Especially 
on highly subjective topics, such as mental benefit, inter-
pretation of the statements was not always unequivocal. 
Nevertheless, these interviews provided very diver-
gent and exemplifying stories that could have not been 
retrieved using standardized questionnaires.
In conclusion, we showed that not all Parkinson’s 
patients with self-reported sleep benefit do experience 
a specific reduction in motor symptoms after sleep. The 
group of patients convincingly reporting sleep benefit 
in a questionnaire turned out to be very heterogeneous, 
with only a portion of the patients describing motor sleep 
benefit. Although the results of qualitative research can-
not be generalized to the whole Parkinson’s population, it 
seems probable that the group of patients actually experi-
encing motor sleep benefit is far smaller than thought so 
far, based on previous questionnaire studies.
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